{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:25:40Z","timestamp":1779344740861,"version":"3.51.4"},"reference-count":312,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1016\/s0166-3542(00)00133-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:56:30Z","timestamp":1027616190000},"page":"143-176","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities"],"prefix":"10.1016","volume":"48","author":[{"given":"Salvatore T.","family":"Butera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0166-3542(00)00133-9_BIB1","doi-asserted-by":"crossref","first-page":"F109","DOI":"10.1097\/00002030-199912030-00001","article-title":"Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART","volume":"13","author":"Aandahl","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB2","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1128\/AAC.42.10.2482","article-title":"Restoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach to chemotherapy against human immunodeficiency virus type1","volume":"42","author":"Achour","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB3","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1073\/pnas.91.9.3862","article-title":"Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts","volume":"91","author":"Adams","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB4","doi-asserted-by":"crossref","first-page":"9698","DOI":"10.1128\/JVI.72.12.9698-9705.1998","article-title":"Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines","volume":"72","author":"Aillet","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1365-3083.2000.00673.x","article-title":"Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patients","volume":"51","author":"Aladdin","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1023\/A:1023246800353","article-title":"Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15, effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production","volume":"18","author":"Al-Harthi","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/514110","article-title":"Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor","volume":"176","author":"Al-Harthi","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB8","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1097\/00002030-199811000-00004","article-title":"Early reduction of immune activation in lymphoid tissue following highly active HIV therapy","volume":"12","author":"Andersson","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/viro.1994.1390","article-title":"NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line","volume":"202","author":"Antoni","year":"1994","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00002030-199807000-00005","article-title":"Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years","volume":"12","author":"Arno","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/314831","article-title":"Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with <\/=250\/microL CD4 T cells and undetectable plasma virus load","volume":"180","author":"Arno","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/314572","article-title":"Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure","volume":"179","author":"Aukrust","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-2478(98)00159-X","article-title":"Restoration of the immune system with anti-retroviral therapy","volume":"66","author":"Autran","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-3542(96)01010-8","article-title":"Cellular factors as alternative targets for inhibition of HIV-1","volume":"33","author":"Baba","year":"1997","journal-title":"Antiviral Res."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/AAC.41.6.1250","article-title":"Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives","volume":"41","author":"Baba","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB17","first-page":"1097","article-title":"Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives","volume":"53","author":"Baba","year":"1998","journal-title":"Mol. Pharm."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB18","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/AAC.43.10.2350","article-title":"Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species","volume":"43","author":"Baba","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry","volume":"10","author":"Bagasra","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB20","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1073\/pnas.89.14.6285","article-title":"CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide","volume":"89","author":"Bagasra","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.95.4.1725","article-title":"Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines","volume":"95","author":"Barker","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/515677","article-title":"Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042","volume":"178","author":"Bartlett","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/CDLI.3.5.547-553.1996","article-title":"Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro","volume":"3","author":"Bayard-McNeeley","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002030-199201000-00001","article-title":"Mechanisms of HIV-1 latency","volume":"6","author":"Bednarik","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB25","first-page":"969","article-title":"DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs","volume":"3","author":"Bednarik","year":"1991","journal-title":"New Biol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB26","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/MCB.13.6.3301","article-title":"Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I\u03baB\u03b1: a mechanism for NF-\u03baB activation","volume":"13","author":"Beg","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03403529","article-title":"Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression","volume":"1","author":"Biswas","year":"1994","journal-title":"Mol. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00042560-199808150-00003","article-title":"Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT","volume":"18","author":"Biswas","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00002030-199905070-00006","article-title":"Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents","volume":"13","author":"Bohler","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/aid.1993.9.1067","article-title":"Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication","volume":"9","author":"Bollinger","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00002030-199811000-00007","article-title":"Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy","volume":"12","author":"Bouscarat","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/350439a0","article-title":"Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity","volume":"350","author":"Braddock","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00126334-199905010-00002","article-title":"HIV-1 reactivation in resting peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands of the CDR2-loop inextracellular domain 1","volume":"21","author":"Briant","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB34","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.4049\/jimmunol.144.8.2961","article-title":"CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor","volume":"144","author":"Brinchmann","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB35","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/JVI.65.4.2019-2023.1991","article-title":"Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection","volume":"65","author":"Brinchmann","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB36","first-page":"647","article-title":"Stimulation of HIV replication in mononuclear phagocytes by leukemia inhibitory factor","volume":"7","author":"Broor","year":"1994","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.1925601","article-title":"Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection","volume":"254","author":"Bukrinsky","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB38","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1073\/pnas.89.14.6580","article-title":"Active nuclear import of human immunodeficiency virus type 1 preintegration complexes","volume":"89","author":"Bukrinsky","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jcb.240530411","article-title":"Cytokine involvement in viral permissiveness and the progression of HIV disease","volume":"53","author":"Butera","year":"1993","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB40","series-title":"Cytokines in Infection, Bailli\u00e8re's Clinical Infectious Diseases","first-page":"109","article-title":"Interrelationships between cytokines and the human immunodeficiency virus","author":"Butera","year":"1994"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB41","series-title":"Methods in Cellular and Molecular Biology: Antiviral Evaluation","first-page":"201","article-title":"Evaluation of compounds that prevent reactivation of HIV-1 in OM-10.1 cells","author":"Butera","year":"1998"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/aid.1992.8.991","article-title":"Application of latent HIV-1 infected cellular models to therapeutic intervention","volume":"8","author":"Butera","year":"1992","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB43","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1128\/JVI.65.9.4645-4653.1991","article-title":"Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ model of chronic infection","volume":"65","author":"Butera","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4049\/jimmunol.150.2.625","article-title":"Regulation of HIV-1 expression by cytokine networks in a CD4+ model of chronic infection","volume":"150","author":"Butera","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB45","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JVI.68.4.2726-2730.1994","article-title":"Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency","volume":"68","author":"Butera","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB46","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/BF03401890","article-title":"Compounds that target novel cellular components involved in HIV-1 transcription","volume":"1","author":"Butera","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0378(98)00056-4","article-title":"Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir","volume":"41","author":"Byrn","year":"1998","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB48","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.163.4.2330","article-title":"Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment","volume":"163","author":"Calarota","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.1992.tb03066.x","article-title":"During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion","volume":"88","author":"Cameron","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB50","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/515653","article-title":"Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethyleneglycol-modified interleukin-2 in human immunodeficiency virus-infected patients:a randomized, controlled, multicenter study. Australian IL-2 Study Group","volume":"178","author":"Carr","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB51","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.276.5314.960","article-title":"Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection","volume":"276","author":"Cavert","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB52","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB53","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1073\/pnas.94.4.1361","article-title":"Highly purified CD25-resting T cells cannot be infected de novo with HIV-1","volume":"94","author":"Chou","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB54","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1073\/pnas.96.20.10958","article-title":"Latent reservoirs of HIV: obstacles to the eradication of virus","volume":"96","author":"Chun","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB55","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB56","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB58","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1128\/JVI.71.6.4436-4444.1997","article-title":"Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI","volume":"71","author":"Chun","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB59","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"Chun","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.188.1.83","article-title":"Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines","volume":"188","author":"Chun","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB61","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/9498","article-title":"Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy","volume":"5","author":"Chun","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB62","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/77481","article-title":"Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy","volume":"6","author":"Chun","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB64","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00002030-199811000-00014","article-title":"Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication","volume":"12","author":"Cinque","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB65","first-page":"15","article-title":"HIV compartmentalization: pathogenesis and clinical implications","volume":"2","author":"Clarke","year":"2000","journal-title":"AIDS Rev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.142.2.431","article-title":"Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone","volume":"142","author":"Clouse","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF03401812","article-title":"The critical role of p38 MAP kinase in T cell HIV-1 replication","volume":"3","author":"Cohen","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4049\/jimmunol.161.2.610","article-title":"Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production","volume":"161","author":"Cole","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm0597-533","article-title":"HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies","volume":"3","author":"Connors","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1086\/514213","article-title":"Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood","volume":"177","author":"Coombs","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02255860","article-title":"A novel complex of proteins binds the HIV-1 promoter upon virus interaction with CD4","volume":"5","author":"Coudronniere","year":"1998","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/aid.1996.12.39","article-title":"Inhibition of HIV activation in latently infected cells by flavonoid compounds","volume":"12","author":"Critchfield","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB73","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1073\/pnas.94.12.6110","article-title":"Casein kinase II is a selective target of HIV-1 transcriptional inhibitors","volume":"94","author":"Critchfield","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632029901000506","article-title":"Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency","volume":"10","author":"Critchfield","year":"1999","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB75","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.11.20.2645","article-title":"The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II","volume":"11","author":"Cujec","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB76","first-page":"826","article-title":"HIV-1 in the female genital tract and the effect of antiretroviral therapy","volume":"12","author":"Cu-Uvin","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB77","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1086\/314464","article-title":"Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients","volume":"178","author":"Dam Nielsen","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB78","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1020547826191","article-title":"Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2","volume":"19","author":"De Paoli","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB80","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB81","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/517308","article-title":"The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels","volume":"176","author":"Dezube","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB82","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/aid.1992.8.245","article-title":"Binding of NF-\u03baB to the HIV-1 LRT is not sufficient to induce HIV-1 LTR activity","volume":"8","author":"Doppler","year":"1992","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB83","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.282.17.1627","article-title":"Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy","volume":"282","author":"Dornadula","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB84","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1128\/JVI.68.7.4302-4313.1994","article-title":"The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication","volume":"68","author":"Duan","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB85","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/viro.1994.1148","article-title":"Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells","volume":"199","author":"Duan","year":"1994","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB86","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.86.15.5974","article-title":"Tumor necrosis factor-alpha activates human immunodeficiency virus-1 through induction of nuclear factor binding to the NF-\u03baB sites in the long terminal repeat","volume":"86","author":"Duh","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB87","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/00002030-199912030-00008","article-title":"Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1infection","volume":"13","author":"Dyrhol-Riise","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/362359a0","article-title":"Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS","volume":"362","author":"Embretson","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB89","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.93.13.6377","article-title":"A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency","volume":"93","author":"Emiliani","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB90","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JVI.72.2.1666-1670.1998","article-title":"Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line","volume":"72","author":"Emiliani","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB91","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(98)00035-7","article-title":"Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells","volume":"39","author":"Evans","year":"1998","journal-title":"Antiviral Res."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/095632029300400107","article-title":"Prevention of activation of HIV-1 by antiviral agents in OM-10.1 cells","volume":"4","author":"Feorino","year":"1993","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB93","doi-asserted-by":"crossref","first-page":"15167","DOI":"10.1073\/pnas.96.26.15167","article-title":"Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy","volume":"96","author":"Ferguson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB94","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.156.2.841","article-title":"IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte\/macrophage lineage","volume":"156","author":"Finnegan","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB95","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0092-8674(00)81427-0","article-title":"Viral dynamics in HIV-1 infection","volume":"93","author":"Finzi","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB96","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB97","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB98","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nm0798-794","article-title":"Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly activeantiretroviral therapy","volume":"4","author":"Fleury","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB99","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1073\/pnas.96.13.7208","article-title":"Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication","volume":"96","author":"Flores","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1084\/jem.164.1.280","article-title":"Biological and biochemical characterization of a cloned Leu-3\u2212 cell surviving infection with the acquired immune deficiency syndrome retrovirus","volume":"164","author":"Folks","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB101","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.3313729","article-title":"Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line","volume":"238","author":"Folks","year":"1987","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB102","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4049\/jimmunol.140.4.1117","article-title":"Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate","volume":"140","author":"Folks","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB103","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.86.7.2365","article-title":"Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone","volume":"86","author":"Folks","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1099\/0022-1317-79-2-221","article-title":"Generation of endogenous tumour necrosis factor-alpha in MOLT-4 cells during the acute replication phase of human immunodeficiency virus type 1 determines the subsequent latent infection","volume":"79","author":"Fujinaga","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-3542(99)00045-5","article-title":"Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells","volume":"43","author":"Fujiwara","year":"1999","journal-title":"Antiviral Res."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB106","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJM199905273402102","article-title":"Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy","volume":"340","author":"Furtado","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB107","doi-asserted-by":"crossref","first-page":"F79","DOI":"10.1097\/00002030-199907300-00002","article-title":"Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy","volume":"13","author":"Garcia","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB108","first-page":"3","article-title":"Structured antiretroviral therapy interruption as a form of immune-based therapy in HIV-1 infection","volume":"2","author":"Garcia","year":"2000","journal-title":"AIDS Rev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB109","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.1658933","article-title":"Molecular basis of latency in pathogenic human viruses","volume":"254","author":"Garcia-Blanco","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-199204000-00001","article-title":"Cellular transcription factors involved in the regulation of HIV-1 gene expression","volume":"6","author":"Gaynor","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB111","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/315351","article-title":"Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy\/liv-SCID-Hu mice","volume":"181","author":"Goldstein","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB112","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/515276","article-title":"The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines","volume":"177","author":"Goletti","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB113","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.1999.tb01337.x","article-title":"Therapeutic vaccines in HIV-1 infection","volume":"170","author":"Gotch","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB114","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/BF03401607","article-title":"Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1","volume":"1","author":"Granowitz","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/339070a0","article-title":"Activation of HIV gene expression during monocytic differentiation by induction of NF-\u03baB","volume":"339","author":"Griffin","year":"1989","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB116","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1073\/pnas.95.11.6314","article-title":"Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication","volume":"95","author":"Grossman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB117","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/13410","article-title":"Ongoing HIV dissemination during HAART","volume":"5","author":"Grossman","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB118","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/MCB.15.6.3450","article-title":"A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat","volume":"15","author":"Gualberto","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB119","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-133-1-200007040-00007","article-title":"Three-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine","volume":"133","author":"Gulick","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB121","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1128\/JVI.73.11.9404-9412.1999","article-title":"Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy","volume":"73","author":"Gunthard","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB122","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1128\/JVI.72.3.2422-2428.1998","article-title":"Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy","volume":"72","author":"Gunthard","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB123","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with hman immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB124","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1073\/pnas.94.8.3548","article-title":"An inhibitor of the Tat\/TAR RNA interaction that effectively suppresses HIV-1 replication","volume":"94","author":"Hamy","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB125","first-page":"865","article-title":"Induction of HIV-1 replication in a chronically infected T-cell line by cytotoxic T lymphocytes","volume":"6","author":"Harrer","year":"1993","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB126","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199905280-00001","article-title":"Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy","volume":"13","author":"Harrigan","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB127","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01718308","article-title":"Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM 10.1","volume":"141","author":"Hashimoto","year":"1996","journal-title":"Arch. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB128","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/377740a0","article-title":"Follicular dendritic cells and human immunodeficiency virus infectivity","volume":"377","author":"Heath","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB129","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1073\/pnas.94.16.8714","article-title":"CCAAT\/enhancer binding protein (C\/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells","volume":"94","author":"Henderson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/088922299311187","article-title":"Lymphocyte kinetics and precursor frequency-dependent recovery of CD4(+)CD45RA(+)CD62L(+) naive T cells following triple-drug therapy for HIV type 1 infection","volume":"15","author":"Hengel","year":"1999","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB131","doi-asserted-by":"crossref","first-page":"F225","DOI":"10.1097\/00002030-199817000-00003","article-title":"Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients","volume":"12","author":"Hengge","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB132","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1128\/JVI.72.12.9881-9888.1998","article-title":"Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines","volume":"72","author":"Herrmann","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB134","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1089\/aid.1998.14.1573","article-title":"Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments","volume":"14","author":"Ho","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB135","first-page":"13","article-title":"Sanctuary sites in HIV-1 infection","volume":"3","author":"Hoetelmans","year":"1998","journal-title":"Antivir. Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB136","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1126\/science.1763331","article-title":"Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist","volume":"254","author":"Hsu","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB137","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00002030-199707000-00003","article-title":"Germinal centre CD4+ T cells are an important site of HIV replication in vivo","volume":"11","author":"Hufert","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB138","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1998.00550.x","article-title":"Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)","volume":"112","author":"Idziorek","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-1702(97)00125-1","article-title":"AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and\/or apoptosis-inducing HIV-1 particles","volume":"52","author":"Ikuta","year":"1997","journal-title":"Virus Res."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/aid.1996.12.569","article-title":"Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR","volume":"12","author":"Jeyaseelan","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB141","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1101\/gad.11.20.2593","article-title":"Taking a new TAK on tat transactivation","volume":"11","author":"Jones","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB142","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1128\/JVI.73.8.6721-6728.1999","article-title":"Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy","volume":"73","author":"Kalams","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB143","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1074-7613(00)80159-4","article-title":"Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection","volume":"12","author":"Kanazawa","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB144","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1128\/JVI.71.11.8456-8466.1997","article-title":"Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo","volume":"71","author":"Kawano","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)81630-X","article-title":"Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells","volume":"95","author":"Kinoshita","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB146","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1128\/JVI.69.12.7507-7518.1995","article-title":"Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells","volume":"69","author":"Kishi","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB147","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1128\/JVI.64.9.4306-4312.1990","article-title":"Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells","volume":"64","author":"Kinter","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB148","doi-asserted-by":"crossref","first-page":"14076","DOI":"10.1073\/pnas.93.24.14076","article-title":"HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines","volume":"93","author":"Kinter","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB149","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.4049\/jimmunol.154.5.2448","article-title":"HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine\/paracrine manner by endogenous cytokines","volume":"154","author":"Kinter","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB150","doi-asserted-by":"crossref","first-page":"10985","DOI":"10.1073\/pnas.92.24.10985","article-title":"Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression","volume":"92","author":"Kinter","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB151","first-page":"249","article-title":"TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals","volume":"1","author":"Klein","year":"1996","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB152","first-page":"47","article-title":"Interleukin-18 stimulates HIV-1 replication in a T-cell line","volume":"11","author":"Klein","year":"2000","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB153","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-\u03baB by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB154","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1128\/JVI.73.8.6526-6532.1999","article-title":"Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes","volume":"73","author":"Korin","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00002030-199806000-00008","article-title":"Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis","volume":"12","author":"Kotler","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB156","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199610313351803","article-title":"Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus","volume":"335","author":"Kovacs","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB157","doi-asserted-by":"crossref","first-page":"F217","DOI":"10.1097\/00002030-199817000-00002","article-title":"Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy","volume":"12","author":"Kroon","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB158","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1128\/JVI.71.10.7560-7566.1997","article-title":"Abrogation of in vitro suppression of human immunodeficiency virus type 1 (HIV-1) replication mediated by CD8+ T lymphocytes of asymptomatic HIV-1 carriers by staphylococcal enterotoxin B and phorbol esters through induction of tumor necrosis factor alpha","volume":"71","author":"Kubo","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB159","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/517307","article-title":"Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments","volume":"176","author":"Lafeuillade","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1086\/517362","article-title":"Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies\/ml","volume":"177","author":"Lafeuillade","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB161","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00042560-200002010-00002","article-title":"Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy","volume":"23","author":"Lambotte","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB162","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/viro.1999.9869","article-title":"Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells","volume":"263","author":"Lapenta","year":"1999","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB163","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00042560-199508000-00002","article-title":"Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B","volume":"9","author":"Laughlin","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB164","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/JVI.74.1.139-145.2000","article-title":"Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection","volume":"74","author":"Lawn","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.185.1.81","article-title":"Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells","volume":"185","author":"Lazdins","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB166","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","article-title":"Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315","volume":"178","author":"Lederman","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB167","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/088922299309847","article-title":"T cell-derived suppressive activity: evidence of autocrine noncytolytic control of HIV type 1 transcription and replication","volume":"15","author":"Leith","year":"1999","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB168","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1126\/science.272.5270.1939","article-title":"Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation","volume":"272","author":"Levine","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB169","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1073\/pnas.91.23.10873","article-title":"Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1","volume":"91","author":"Levy","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00002030-199807000-00008","article-title":"HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals","volume":"12","author":"Lewin","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB171","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.90.5.1839","article-title":"Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication","volume":"90","author":"Li","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB172","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3301088","article-title":"Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated anti-tat gene transfer","volume":"7","author":"Li","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB173","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/clin.1996.4292","article-title":"Derivation of herpesvirus saimiri-transformed CD8+ T cell lines with noncytotoxic anti-HIV activity","volume":"82","author":"Mackewicz","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB174","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/0022-1317-81-5-1261","article-title":"CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration","volume":"81","author":"Mackewicz","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB175","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1101\/gad.11.20.2633","article-title":"P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro","volume":"11","author":"Mancebo","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB176","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-1759(99)00159-3","article-title":"Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS","volume":"231","author":"Marasco","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB177","doi-asserted-by":"crossref","first-page":"11958","DOI":"10.1073\/pnas.96.21.11958","article-title":"Productive infection of double-negative T cells with HIV in vivo","volume":"96","author":"Marodon","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB178","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.4049\/jimmunol.162.10.6016","article-title":"Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha","volume":"162","author":"Marshall","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB179","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/viro.1999.9601","article-title":"Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia","volume":"256","author":"Martinez","year":"1999","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB180","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/514775","article-title":"Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy","volume":"28","author":"Mayer","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB181","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.96.20.11482","article-title":"An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro","volume":"96","author":"McCoig","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB182","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0092-8674(95)90305-4","article-title":"Viral latency in HIV disease","volume":"82","author":"McCune","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB183","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1073\/pnas.92.9.3707","article-title":"In vivo estimates of division and death rates of human T lymphocytes","volume":"92","author":"McLean","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB184","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1089\/10430349950017798","article-title":"Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies","volume":"10","author":"Mhashilkar","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/JVI.66.1.310-316.1992","article-title":"Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease","volume":"66","author":"Michael","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB186","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00002030-199105000-00004","article-title":"Inhibition of HIV-1 replication and NF-\u03baB activity by cysteine and cysteine derivatives","volume":"5","author":"Mihm","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB187","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1084\/jem.179.1.101","article-title":"The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages","volume":"179","author":"Miller","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB188","doi-asserted-by":"crossref","unstructured":"Mikovits, J.A., Raziuddin, Gonda, M., Ruta, M., Lohrey, N.C., Kung, H.F., Ruscetti, F.W., 1990. Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP-1 cells. J. Exp. Med. 171, 1705\u201320.","DOI":"10.1084\/jem.171.5.1705"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB189","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI116016","article-title":"Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo","volume":"90","author":"Mikovits","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB190","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1099\/0022-1317-78-4-825","article-title":"The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells","volume":"78","author":"Mlynar","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB191","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group","volume":"352","author":"Mocroft","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB192","doi-asserted-by":"crossref","first-page":"15341","DOI":"10.1073\/pnas.93.26.15341","article-title":"CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES., MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte\/macrophages","volume":"93","author":"Moriuchi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB193","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.187.10.1689","article-title":"Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1","volume":"187","author":"Moriuchi","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB194","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.4049\/jimmunol.162.12.7543","article-title":"Induction of HIV-1 replication by allogeneic stimulation","volume":"162","author":"Moriuchi","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB195","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1086\/315496","article-title":"In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation","volume":"181","author":"Moriuchi","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB196","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/aid.1998.14.39","article-title":"9-Nitrocamptothecin inhibits tumor necosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone","volume":"14","author":"Moulton","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB197","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0091-6749(97)70282-3","article-title":"Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation","volume":"100","author":"Munoz-Fernandez","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB198","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1128\/JVI.73.11.9021-9028.1999","article-title":"Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct","volume":"73","author":"Muto","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB199","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/JVI.71.2.1718-1725.1997","article-title":"Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR","volume":"71","author":"Nagai","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(05)76156-0","article-title":"HIV-1 replication in patients with undetectable plasma virus receiving HAART","volume":"353","author":"Natarajan","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB201","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1128\/JVI.72.6.4712-4720.1998","article-title":"Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT","volume":"72","author":"Navarro","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199605000-00004","article-title":"Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation","volume":"10","author":"Navarro","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00002030-199904160-00008","article-title":"HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group","volume":"13","author":"Neumann","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(96)00193-7","article-title":"In vitro separation and expansion of CD4 lymphocytes from HIV-infected individuals without activation of HIV infection","volume":"200","author":"Nielsen","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB205","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/517434","article-title":"Effect of granulocyte colony-stimulating factor (G-CSF) in human immunodeficiency virus-infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy","volume":"177","author":"Nielsen","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB206","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/aid.1998.14.1239","article-title":"Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells","volume":"14","author":"Okamoto","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB207","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/AAC.43.3.492","article-title":"Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells","volume":"43","author":"Okamoto","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB208","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1126\/science.276.5320.1857","article-title":"Macrophages as a source of HIV during opportunistic infections","volume":"276","author":"Orenstein","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB209","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1073\/pnas.86.7.2336","article-title":"Tumor necrosis factor \u03b1 and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor \u03baB","volume":"86","author":"Osborn","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB210","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.73.8.6430-6435.1999","article-title":"Both memory and CD45RA+\/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals","volume":"73","author":"Ostrowski","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002030-199902040-00008","article-title":"Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group","volume":"13","author":"Pakker","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB212","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB213","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/clim.2000.4837","article-title":"Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART","volume":"94","author":"Pandolfi","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB214","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm0597-483","article-title":"How immune-based interventions can change HIV therapy","volume":"3","author":"Pantaleo","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB215","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1073\/pnas.88.21.9838","article-title":"Lymphoid organs function as major reservoirs for human immunodeficiency virus","volume":"88","author":"Pantaleo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB216","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/362355a0","article-title":"HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease","volume":"362","author":"Pantaleo","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB217","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nm0398-341","article-title":"Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy","volume":"4","author":"Pantaleo","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB218","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1101\/gad.10.1.37","article-title":"NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro","volume":"10","author":"Pazin","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB219","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy","volume":"387","author":"Perelson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB220","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.4049\/jimmunol.147.9.3145","article-title":"An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation","volume":"147","author":"Perez","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB221","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/j.1460-2075.1993.tb06029.x","article-title":"A cooperative interaction between NF-\u03baB and Sp1 is required for HIV-1 enhancer activation","volume":"12","author":"Perkins","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB222","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/515303","article-title":"Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy","volume":"177","author":"Perrin","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB223","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.8096089","article-title":"High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR","volume":"259","author":"Piatak","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB224","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/8400","article-title":"HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1infection, but decline with prolonged viral suppression","volume":"5","author":"Pitcher","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB225","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(05)60532-6","article-title":"Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study","volume":"352","author":"Plana","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB226","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1073\/pnas.87.2.782","article-title":"Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression","volume":"87","author":"Poli","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB227","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1084\/jem.172.1.151","article-title":"Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms","volume":"172","author":"Poli","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB228","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.173.3.589","article-title":"Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte\/macrophage lineage","volume":"173","author":"Poli","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB229","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1073\/pnas.91.1.108","article-title":"Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist","volume":"91","author":"Poli","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB230","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0092-8674(90)90691-7","article-title":"Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency","volume":"61","author":"Pomerantz","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB231","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.172.1.253","article-title":"Lipopolysaccharide is a potent monocyte\/macrophage-specific stimulator of human immunodeficiency virus type 1 expression","volume":"172","author":"Pomerantz","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB232","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/JVI.66.3.1809-1813.1992","article-title":"Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency","volume":"66","author":"Pomerantz","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB233","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00002030-199912030-00012","article-title":"Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy","volume":"13","author":"Prins","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB234","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1073\/pnas.90.10.4674","article-title":"G\u00f6 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent\/low-level-producing reservoir cells in vitro","volume":"90","author":"Qatsha","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00042560-199812010-00002","article-title":"Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells","volume":"19","author":"Rabbi","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB236","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.gt.3300474","article-title":"Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes","volume":"4","author":"Ramezani","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB237","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/71577","article-title":"The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy","volume":"6","author":"Ramratnam","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.173.1.1","article-title":"Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1","volume":"173","author":"Rieckmann","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB239","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1128\/JVI.72.10.8273-8280.1998","article-title":"Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis","volume":"72","author":"Riley","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB240","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/aid.1991.7.563","article-title":"N-acetyl cysteine inhibits latent HIV expression in chronically infected cells","volume":"7","author":"Roederer","year":"1991","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB241","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI119318","article-title":"HIV does not replicate in naive CD4 T cells stimulated with CD3\/CD28","volume":"99","author":"Roederer","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB242","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB243","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.1073\/pnas.94.17.9332","article-title":"Correlates of latent and productive HIV type-1 infection in tonsillar CD4(+) T cells","volume":"94","author":"Rosok","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB244","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/aid.1997.13.79","article-title":"CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells","volume":"13","author":"Rosok","year":"1997","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB245","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.gt.3300522","article-title":"Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients","volume":"4","author":"Rossi","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB246","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.175.3.751","article-title":"Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells","volume":"175","author":"Roulston","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB247","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/viro.1997.8872","article-title":"Megalomicin inhibits HIV-1 replication and interferes with gp160 processing","volume":"239","author":"San Jose","year":"1997","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB248","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/aid.1998.14.293","article-title":"Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine\/threonine kinase inhibitor, fasudil hydrochloride","volume":"14","author":"Sato","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB249","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(00)80350-5","article-title":"Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection","volume":"90","author":"Schnell","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.2665081","article-title":"The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4","volume":"245","author":"Schnittman","year":"1989","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB251","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.4049\/jimmunol.147.8.2553","article-title":"Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells","volume":"147","author":"Schnittman","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB252","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.280.1.67","article-title":"Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy","volume":"280","author":"Schrager","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB253","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jlb.64.3.298","article-title":"HIV load in highly purified CD8+ T cells retrieved from pulmonary and blood compartments","volume":"64","author":"Semenzato","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB254","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.89.22.10663","article-title":"Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1","volume":"89","author":"Seshamma","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB255","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1073\/pnas.95.13.7422","article-title":"Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro","volume":"95","author":"Shapiro","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB256","doi-asserted-by":"crossref","first-page":"12550","DOI":"10.1073\/pnas.95.21.12550","article-title":"Interleukin 18 stimulates HIV type 1 in monocytic cells","volume":"95","author":"Shapiro","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB257","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/71569","article-title":"Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy","volume":"6","author":"Sharkey","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB258","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/infdis\/174.1.54","article-title":"Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway","volume":"174","author":"Shattock","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB259","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4049\/jimmunol.156.6.2324","article-title":"IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells","volume":"156","author":"Smithgall","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB260","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/viro.1996.0612","article-title":"Rates of shutdown of HIV-1 into latency: roles of the LTR and tat\/rev\/vpu gene region","volume":"225","author":"Song","year":"1996","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB261","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood.V95.5.1743.005k14_1743_1751","article-title":"Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality","volume":"95","author":"Soudeyns","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB262","first-page":"15","article-title":"Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells","volume":"140","author":"Spiegel","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB263","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.179.1.115","article-title":"The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes","volume":"179","author":"Spina","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB264","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/JVI.69.5.2977-2988.1995","article-title":"Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro","volume":"69","author":"Spina","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB265","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI119342","article-title":"Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro","volume":"99","author":"Spina","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB266","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.145.4.1120","article-title":"Heat shock induction of HIV production from chronically infected promonocytic and T cell lines","volume":"145","author":"Stanley","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB267","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1084\/jem.182.6.1727","article-title":"Activation of virus replication after vaccination of HIV-1-infected individuals","volume":"182","author":"Staprans","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB268","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00002030-199709000-00004","article-title":"Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells","volume":"11","author":"Stellbrink","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB269","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/135965359800300409","article-title":"Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2","volume":"3","author":"Stellbrink","year":"1998","journal-title":"Antivir. Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB270","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/j.1460-2075.1990.tb08274.x","article-title":"HIV-1 replication is controlled at the level of T cell activation and proviral integration","volume":"9","author":"Stevenson","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB271","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.8096091","article-title":"NF-\u03baB controls expression of inhibitor I\u03baB\u03b1: evidence for an inducible autoregulatory pathway","volume":"259","author":"Sun","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB272","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.189.9.1391","article-title":"Expression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells","volume":"189","author":"Sun","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB273","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1128\/JVI.69.9.5659-5665.1995","article-title":"Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation","volume":"69","author":"Tang","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB274","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.187.6.949","article-title":"The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy","volume":"187","author":"Tenner-Racz","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB275","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1357-4310(95)91208-8","article-title":"Cyclosporins: immunosuppressive drugs with anti-HIV-1 activity","volume":"1","author":"Thali","year":"1995","journal-title":"Mol. Med. Today"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB276","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00042560-199708150-00001","article-title":"Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro","volume":"15","author":"Toossi","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB277","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jmv.1890270105","article-title":"Persistent productive HIV infection in EBV-transformed B lymphocytes","volume":"27","author":"Tozzi","year":"1989","journal-title":"J. Med. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB278","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/intimm\/11.2.143","article-title":"Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells","volume":"11","author":"Traber","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB279","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1128\/JVI.73.8.7008-7013.1999","article-title":"Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells","volume":"73","author":"Truong","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB280","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.42.3.487","article-title":"Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription","volume":"42","author":"Turpin","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB281","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.189.11.1735","article-title":"Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes","volume":"189","author":"Unutmaz","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB282","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/j.1460-2075.1996.tb00449.x","article-title":"Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation","volume":"15","author":"Van Lint","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB283","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/j.1460-2075.1993.tb05994.x","article-title":"Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation","volume":"12","author":"Verdin","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB284","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm0997-938","article-title":"IL-16 anti-HIV-1 therapy","volume":"3","author":"Viglianti","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB285","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1099\/0022-1317-74-11-2401","article-title":"Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-kappa B-independent mechanism","volume":"74","author":"Vlach","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB286","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00002030-199001000-00003","article-title":"Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication","volume":"4","author":"Vyakarnam","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB287","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jlb.62.1.67","article-title":"Immune stimulation and HIV-1 viral replication","volume":"62","author":"Wahl","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB288","first-page":"628","article-title":"A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication","volume":"66","author":"Walker","year":"1989","journal-title":"Immunology."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB289","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1128\/JVI.65.11.5921-5927.1991","article-title":"Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism","volume":"65","author":"Walker","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB290","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/1521-4141(200002)30:2<577::AID-IMMU577>3.0.CO;2-Y","article-title":"CD7 expression distinguishes subsets of CD4(+) T cells with distinct functional properties and ability to support replication of HIV-1","volume":"30","author":"Wallace","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB291","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80939-3","article-title":"A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA","volume":"92","author":"Wei","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB292","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB293","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1089\/aid.1994.10.1199","article-title":"Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus","volume":"10","author":"Weissman","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB294","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/aid.1996.12.759","article-title":"Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions","volume":"12","author":"Weissman","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/314833","article-title":"CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia","volume":"180","author":"Wilkinson","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB296","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/viro.1993.1545","article-title":"HIV-1 latency due to the site of proviral integration","volume":"196","author":"Winslow","year":"1993","journal-title":"Virology"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB297","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/095632029800900504","article-title":"Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12","volume":"9","author":"Witvrouw","year":"1998","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB298","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB299","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1089\/hum.1998.9.16-2407","article-title":"A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA","volume":"9","author":"Wong-Staal","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB300","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood.V89.5.1635","article-title":"Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells","volume":"89","author":"Woods","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB301","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)80713-8","article-title":"NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation","volume":"97","author":"Yamaguchi","year":"1999","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB302","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1084\/jem.187.7.1139","article-title":"Productive infection of neonatal CD8+ T lymphocytes by HIV-1","volume":"187","author":"Yang","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB303","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90802-L","article-title":"HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure","volume":"61","author":"Zack","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB304","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/JVI.66.3.1717-1725.1992","article-title":"Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle","volume":"66","author":"Zack","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1086\/314880","article-title":"Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia","volume":"180","author":"Zaunders","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB306","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.41.5.977","article-title":"Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I","volume":"41","author":"Zhang","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB307","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy","volume":"340","author":"Zhang","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB308","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1126\/science.286.5443.1353","article-title":"Sexual transmission and propagation of SIV and HIV in resting and activated CD4+T cells","volume":"286","author":"Zhang","year":"1999","journal-title":"Science"},{"key":"10.1016\/S0166-3542(00)00133-9_BIB309","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1128\/MCB.20.14.5077-5086.2000","article-title":"Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription","volume":"20","author":"Zhou","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB310","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nm0697-659","article-title":"Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression","volume":"3","author":"Zhou","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB311","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4049\/jimmunol.163.2.906","article-title":"Processing, secretion, and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells","volume":"163","author":"Zhou","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0166-3542(00)00133-9_BIB312","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1101\/gad.11.20.2622","article-title":"Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro","volume":"11","author":"Zhu","year":"1997","journal-title":"Genes Dev."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354200001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354200001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T14:09:11Z","timestamp":1681135751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354200001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":312,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0166354200001339"],"URL":"https:\/\/doi.org\/10.1016\/s0166-3542(00)00133-9","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}